Study Finds CBD Inneffective for Chronic Pain Management
A new study published in The Journal of Pain found that cannabidiol (CBD) was ineffective in treating chronic pain. The…
Browsing: Cannabinoids
Florida Bill to Regulate Hemp-Derived Products Advances
The Florida Senate recently voted to restrict the sale of intoxicating cannabinoid products. SB 1698 addresses health and safety concerns…
Why Congress and the FDA Must Regulate CBD Consumer Products Now
On January 3, 2024, CareTalk published an opinion piece authored by Michael C. Barnes, Counsel to Aimed Alliance. The article…
Urgent Calls for Federal Oversight of Hemp-Derived Cannabinoids Amid Rising Child Hospitalizations
In a recent article, the Wall Street Journal highlights how hundreds of children are being rushed to hospitals after unintentionally…
From Farm Bill to FDA: The Legal Landscape of CBD
In this CareTalk episode, host David Williams discusses the legal landscape of CBD with Michael C. Barnes, Counsel to Aimed…
Women Legislators Seek Regulation of Products Containing Hemp-Derived Cannabinoids
FOR IMMEDIATE RELEASE Women Legislators Seek Regulation of Products Containing Hemp-Derived Cannabinoids Washington, DC — December 6, 2023 — The…
Cannabinoid Clarity: The Need for Federal Legislation
On November 18, 2023, Aimed Alliance attorneys spoke at the annual conference of the National Foundation for Women Legislators (NFWL)…
Aimed Alliance Counsel Discusses Cannabinoids, Opioids at Nurses Conference
On September 22, 2023, Michael C. Barnes, Counsel to Aimed Alliance, participated in a panel discussion on health policy at…
Congress Requests Information on Regulation of CBD
On July 27, 2023, a bipartisan group of lawmakers issued a Request for Information (RFI) regarding the regulation of hemp-derived…
SAMHSA’s Fact Sheet Underscores the Potential Risks of CBD
The rising popularity of cannabidiol (CBD) has ignited conversations about its potential benefits, but SAMHSA’s advisory fact sheet sheds light…